Enzymedica MucoStop 48 Capsules Free USA Shipping

This product contains a blend of enzymes formulated to break down mucous and reduce histamine.

The active ingredient is a potent mucolytic enzyme which has been studied for its effectiveness at reducing mucus and is combined with proteases and amylases blended to assist in overcoming the symptoms often associated with sinus and chest congestion.

Nutritional Information Serving Size: 2 capsules Capsules Per Container: 12 & 48 Amount Per Capsule: Amylase Thera-blend Protease Thera-blend Glucoamylase Betaglucanase Lipase Thera-blend Alpha-Galactosidase Cellulase Thera-blend Xylanase Seaprose Pectinase w/ Phytase Hemmicellulase Invertase 14,850 DU 45,000 HUT 50 AG 60 BGU 500 FCCFIP 100 GalU 400 CU 550 XU 15 Mg 350endo-Pgu 30 HCU 5 INVU This product contain no fillers.

Recommended Usage of MucoStop™ Mucolytic Enzyme Formula Suggested Use: Two capsules, three times a day on an empty stomach.

Children and sensitive individuals: One capsule, three times a day on an empty stomach.

Store in a cool dry place. Keep out of reach of children.

MucoStop™ Mucolytic Enzyme Formula: Break Down Mucus Mucus is defined as the clear viscid secretion of the mucus membranes, consisting of mucin, epithelial cells and leukocytes.

Enzymes classified as proteolytic (breaks down protein) and mucolytic (breaks down mucus) are beneficial at breaking down mucus.

Proteolytic enzymes are enzymes that break down proteins. Not all proteases, however, can break down all proteins. For example, a protease that is an effective digester of food protein will not be a good protease for mucous protein. The mucous protein requires an enzyme classified as proteolytic and mucolytic (breaks down mucous). Seaprose stands alone in this category.

Seaprose Seaprose has at least six separate studies to support the effect it has on individuals with bronchial and sinus mucus as well as inflammatory issues. In one study it stated: "Eight days after the end of treatment with seaprose, there was still a significant beneficial effect on the viscoelasticity of mucus and a sort of "post-mucolytic effect" can be postulated. The enzyme Seaprose also had anti-inflammatory action and since in chronic bronchitis there are variable degrees of inflammations, its beneficial long-lasting effect could also be ascribed to this concomitant action."

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease